Apply Now! 2020 ATS Fellow Application Opens
The ATS Fellow designation is a mark of distinction that recognizes the accomplishments, dedication, and contributions of ATS members to the Society and the fields of pulmonary, critical care, and sleep medicine.
If you have been an ATS member for five or more years, consider applying. Applicants must complete an application and submit two letters of reference in addition to a personal statement.
Applications will be accepted through Aug. 31, 2020. Learn more!
ATS Research Program: Apply now!
The ATS Research Program advances the fight against respiratory diseases by providing funding for junior investigators, partnering with other nonprofit organizations and pharmaceutical companies to maximize the number of grants available. The ATS reviews all grants and assumes all costs associated with administrating the grants.
The 2020 grant cycle is officially open! Apply now!
This year, the ATS is also offering two GSK-funded COVID-19 specific research grants, as well as the ATS CHEST Foundation Research Grant in Diversity. While not specific to COVID-19, ATS CHEST Foundation Research Grant in Diversity, given the disproportionate impact of COVID-19 on communities of color, researchers with an interest in COVID-19 research are encouraged to apply.
You can also invest in respiratory, critical care, and sleep, as well as early career investigators, by making a gift to the ATS today. Hear from other donors, and learn more about the 2019 awardees!
ATS Recognizes World No Tobacco Day
On World No Tobacco Day, recognized annually on May 31, 2020, the Forum of International Respiratory Societies (FIRS), called on governments and policymakers to implement stronger measures to protect teenagers and adolescents from tobacco industry marketing, in order to safeguard health and to support global public health goals for a tobacco-free generation. The ATS is a founding member of FIRS.
The call is issued in support of the World Health Organization’s (WHO) overarching World No Tobacco Day (WNTD) 2020 theme, which focuses on exposing the strategies used by the tobacco industry to appeal to young people in its marketing of novel tobacco and nicotine products such as e-cigarettes, heated tobacco and “smokeless” tobacco products.
ATS Cannabis Industry Policy
As of June 1, 2020, a new ATS Board-enacted policy restricts members from assuming an official ATS role if they have had a professional relationship or personal investment with any cannabis entity that promotes recreational use and/or non-evidence-based uses of inhaled cannabis products. The policy also includes criteria for research funded by cannabis entities submitted for publication in ATS Journals.
Developed by a working group of the Ethics and Conflict of Interest and Tobacco Action committees, in consultation with the Environmental, Occupational and Population Health Assembly, the policy was created in response to member concern about the lung health effects of recreational use of inhaled cannabis products, as well as tobacco industry acquisitions of cannabis companies. It will not limit plans for ATS 2020 Virtual, projects in development, or journal manuscripts previously submitted.
You can read the full policy now. Please contact Shane McDermott, senior director, Ethics and Professionalism with any questions.
Join Us!
Upcoming Webinar: Talking to Parents about Tobacco Dependence: Important Skills for the Pediatric Health Care Provider
Join the PEDS Advocacy Sub-Committee for, “Talking to Parents about Tobacco Dependence: Important Skills for the Pediatric Health Care Provider.”
When: 2:30 p.m. ET, June 10, 2020
Where: Online. Register now!
ATS 2020 Virtual: Clinical Trials Session
Join us for ““Breaking News: Clinical Trial Results in Pulmonary Medicine.” Designed for clinicians, research scientists, and other allied health professionals, this session will provide you with late-breaking information on leading clinical trials affecting the pulmonary, critical care, and sleep community.
When: 2 p.m. ET, June 24, 2020
Where: Online. Register now!
The Impact of CFTR Modulators on Sexual and Reproductive Health
As part of "Cystic Fibrosis Week at the ATS" and in conjunction with PAR partner Cystic Fibrosis Research Inc, the American Thoracic Society will host a webinar, "The Impact of CFTR Modulators on Sexual and Reproductive Health" and will be presented by Jennifer Taylor-Cousar, MD, MSCS of National Jewish Health. The patient's perspective will be given by Gillian Mocek.
When: 2:30 p.m. ET, June 10, 2020
Where: Online. Register now!
